40. Sakamoto N, Sun Z, Brengman ML, Maemura K, Ozaki M, et al. (2003) Hepatic reticuloendothelial system dysfunction after ischemia-reperfusion: role of P-selectin-mediated neutrophil accumulation. Liver Transpl 9: 940–948. 41. Possamai LA, Antoniades CG, Anstee QM, Quaglia A, Vergani D, et al. (2010) Role of monocytes and macrophages in experimental and human acute liver failure. World J Gastroenterol 16: 1811–1819. 42. Harstad EB, Klaassen CD (2002) Gadolinium chloride pretreatment prevents cadmium chloride-induced liver damage in both wild-type and MT-null mice. Toxicol Appl Pharmacol 180: 178–185. 43. Bourdi M, Davies JS, Pohl LR (2011) Mispairing C57BL/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injury. Chem Res Toxicol 24: 794–796. 44. Hoetzel A, Vagts DA, Loop T, Humar M, Bauer M, et al. (2001) Effect of nitric oxide on shock-induced hepatic heme oxygenase-1 expression in the rat. Hepatology 33: 925–937. 45. Lehmann V, Freudenberg MA, Galanos C (1987) Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine- treated mice. J Exp Med 165: 657–663. 46. Knight TR, Jaeschke H (2002) Acetaminophen-induced inhibition of Fas receptor-mediated liver cell apoptosis: mitochondrial dysfunction versus glutathione depletion. Toxicol Appl Pharmacol 181: 133–141. 47. Le Moine O, Louis H, Demols A, Desalle F, Demoor F, et al. (2000) Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology 31: 1266–1274. 48. Ruckert R, Brandt K, Ernst M, Marienfeld K, Csernok E, et al. (2009) Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis? Immunology 126: 63–73. 49. Nishimura H, Washizu J, Nakamura N, Enomoto A, Yoshikai Y (1998) Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA. J Immunol 160: 936–942. Effect of IL-15 on APAP Hepatitis 50. Meazza R, Verdiani S, Biassoni R, Coppolecchia M, Gaggero A, et al. (1996) Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 12: 2187–2192. 51. Onu A, Pohl T, Krause H, Bulfone-Paus S (1997) Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol 158: 255–262. 52. Tagaya Y, Kurys G, Thies TA, Losi JM, Azimi N, et al. (1997) Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci U S A 94: 14444–14449. 53. Musikacharoen T, Oguma A, Yoshikai Y, Chiba N, Masuda A, et al. (2005) Interleukin-15 induces IL-12 receptor beta1 gene expression through PU.1 and IRF 3 by targeting chromatin remodeling. Blood 105: 711–720. 54. Mirghomizadeh F, Bullwinkel J, Orinska Z, Janssen O, Petersen A, et al. (2009) Transcriptional regulation of mouse mast cell protease-2 by interleukin-15. J Biol Chem 284: 32635–32641. 55. Yoshihara K, Yajima T, Kubo C, Yoshikai Y (2006) Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 55: 334–341. 56. Nakamura R, Maeda N, Shibata K, Yamada H, Kase T, et al. (2010) Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury. J Virol 84: 5574–5582. 57. Shinozaki M, Hirahashi J, Lebedeva T, Liew FY, Salant DJ, et al. (2002) IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis. J Clin Invest 109: 951–960. 58. Gomez-Nicola D, Spagnolo A, Guaza C, Nieto-Sampedro M (2010) Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice. Exp Neurol 222: 235–242. 59. Conti F, Frappier J, Dharancy S, Chereau C, Houssin D, et al. (2003) Interleukin-15 production during liver allograft rejection in humans. Trans- plantation 76: 210–216. 60. Kakumu S, Okumura A, Ishikawa T, Yano M, Enomoto A, et al. (1997) Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin Exp Immunol 109: 458–463. PLOS ONE | www.plosone.org 14 September 2012 | Volume 7 | Issue 9 | e44880